Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

779407

Sigma-Aldrich

4-Pentyn-1-amine

≥92.0%

Synonym(s):

1-Amino-4-pentyne, 4-Pentynylamine, 5-Amino-1-pentyne

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
H2NCH2CH2C≡CH
CAS Number:
15252-44-5
Molecular Weight:
83.13
Beilstein:
2232239
MDL number:
MFCD09923611
UNSPSC Code:
12352100
PubChem Substance ID:
329768035
NACRES:
NA.22

Assay

≥92.0%

form

liquid

reaction suitability

reaction type: click chemistry

density

0.859 g/mL at 20 °C

storage temp.

2-8°C

SMILES string

NCCCC#C

InChI

1S/C5H9N/c1-2-3-4-5-6/h1H,3-6H2

InChI key

LMDDPGHBJXJGAC-UHFFFAOYSA-N

Packaging

Bottomless glass bottle. Contents are inside inserted fused cone.

Pictograms

FlameCorrosion
GHS02,GHS05

Signal Word

Danger

Hazard Statements

H225,H314

Hazard Classifications

Flam. Liq. 2 - Skin Corr. 1B

Storage Class Code

3 - Flammable liquids

WGK

WGK 3

Flash Point(F)

50.0 - 59.0 °F

Flash Point(C)

10 - 15 °C

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

FSL

Group 4: Flammable liquids
Type 1 petroleums
Hazardous rank II
Water insoluble liquid

JAN Code

779407-500MG:
779407-VAR:
779407-BULK:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCBR0320V
BCBP7933V
BCBN1621V
BCBM9757V
BCBM7163V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Nicolò Mauro et al.
International journal of pharmaceutics, 555, 207-219 (2018-11-21)
The extremely complex tumor microenvironment (TME) in humans is the major responsible for the therapeutic failure in cancer nanomedicine. A new concept of disease-driven nanomedicine, henceforth named "Theranomics", which attempts to target cancer cells and TME on the whole, represents

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service